Uncategorized
Share this news article...
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Email this to someone
email

Marapharm Ventures Inc. Closes Oversubscribed Financing for $4.5 million

 

 

 

 

 

Marapharm Ventures Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) is pleased to announce that the non-brokered private placement unit offering announced in a news release on May 17, 2018, for gross proceeds of $4,000,000 has closed oversubscribed for total gross proceeds of $4,500,000.

 

 

The non-brokered private placement of 7,500,000 Units at CDN $0.60 per Unit the Unit consists of one common share of the Company and one-half of one common share purchase warrant of the Company.  Each warrant entitles the holder thereof to purchase one Common Share of the Company at an exercise price of $0.70 for a period of 12 months from the date of issuance of the warrant.

 

 

Pursuant to the terms of the warrants, the expiry date of the warrants may be accelerated should the closing price at which the common shares trade exceeds $0.85 for five consecutive trading days. Any warrants which remain unexercised after the accelerated expiry date will be cancelled.

 

 

The net proceeds raised from the Unit Offering are intended to be used for (i) further development of the Company’s Las Vegas project (ii) further development of the Company’s project in Washington State (iii) further development of the Company’s projects in California and general corporate purposes. The common shares and warrants issued pursuant to the non-brokered offering are subject to a four month hold period. No finder’s fees will be paid in connection with this non-brokered offering.

 

 

“We are weeks away from entering production at our newly built facilities in Nevada. 2018 will be the first revenue producing year for the Company, we are passionate about our future and excited to achieve these significant milestones,” Linda Sampson, CEO.

 

 

ABOUT MARAPHARM VENTURES INC.

 

 

Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm has rapidly expanded to include having cultivation, production and dispensary locations in the key North American states of Washington, Nevada, and California, and are seeking expansion opportunities worldwide. 

 

Posted May 22, 2018

Share this news article...
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Email this to someone
email

MORE or "UNCATEGORIZED"


Khiron Announces Closing of $28.75 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option

Khiron Life Sciences Corp. (TSX-V:KHRN) (OTCQB:KHRNF), a cannabis... READ MORE

May 28, 2019

Harborside Closes C$19.65 Million Financing

FLRish Inc. d/b/a/ Harborside, a California corporation which man... READ MORE

May 28, 2019

TerrAscend Announces Closing on $69 Million Non-Brokered Private Placement

TerrAscend Corp. (CSE:TER) (OTCQX:TRSSF) has completed its previo... READ MORE

May 28, 2019

Construction of a hydroelectric generating station for the energy transition in the Inukjuak off-grid system

Innergex Renewable Energy Inc. (TSX: INE) the Pituvik Landholding... READ MORE

May 27, 2019

C21 Investments completes acquisition of Swell Companies

C21 Investments Inc. (CSE: CXXI) (OTC: CXXIF) today announced tha... READ MORE

May 27, 2019

Copyright 2025 The Venture Report